Agios Pharmaceuticals (AGIO) EBITDA Margin Growth (1y) (2013 - 2026)
Agios Pharmaceuticals (AGIO) EBITDA Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | 69,163.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,163.00 |
| Dec 31, 2025 | 55,641.00 |
| Sep 30, 2025 | 23,956.00 |
| Jun 30, 2025 | 20,817.00 |
| Mar 31, 2025 | -9,763.00 |
| Dec 31, 2024 | 33,092.00 |
| Sep 30, 2024 | 21,673.00 |
| Jun 30, 2024 | 16,772.00 |
| Mar 31, 2024 | 49,116.00 |
| Dec 31, 2023 | 80,475.00 |
| Sep 30, 2023 | 122,707.00 |
| Jun 30, 2023 | 35,319.00 |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2020 | 8,903.00 |
| Sep 30, 2020 | 18,773.00 |
| Jun 30, 2020 | 21,129.00 |
| Mar 31, 2020 | 22,258.00 |
| Dec 31, 2019 | 2,215.00 |
| Sep 30, 2019 | 23,339.00 |
| Jun 30, 2019 | -25,373.00 |